2 November 2023

A&O advises Shionogi on its strategic joint venture with Apnimed for the development of therapies for obstructive sleep apnea and other sleep disorders

Advising firms

10 lawyers named

The named deal team is included with full access

Full access shows the lawyers on every deal team, disclosed values, clients and counterparties.

Deal value, client and counterparties are included with full access

Full access shows the disclosed value and what it refers to, the client and every counterparty.